Article Details
Retrieved on: 2025-07-28 18:44:20
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Monoclonal antibodies that block CGRP, or its receptor, have been proven effective in the preventive treatment of chronic migraine (CM) in several ...
Article found on: thejournalofheadacheandpain.biomedcentral.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here